Inhaled Sterioids Increase Diabetes Risk in COPD Patients

The use inhaled corticosteroids has been linked to a heightened risk of developing type 2 diabetes.

The study published in the American Journal of Medicine indicated that patients with chronic obstructive pulmonary disorder or COPD who use these drugs should pay special attention to this warning.  Drugs include  fluticasone (Flonase, Advair), budesonide (Pulmicort, Rhinocort) and beclometasone (QVAR, Beclovent).  These drugs are also prescribed to people with asthma, but researchers say that their diabetes risk is not nearly as significant as it is for COPD patients.


Learn about natural treatment options for diabetes at our website.

For information about how other drugs can harm the body and the eyes, click here.